Newsletter Signup
Where current and emerging technology trends meet.
TecTrendsInformation Sources, Inc.
  | About TecTrends | Email Signup | Contact Us
 Live Search:
Live Search | Articles | Companies | TecTerms | Products
  Loading TecTrends Live Search - please wait... 
View Noteworthy Articles      PRNewswire
 
Company

CardioVascular BioTherapeutics Inc Products   
1635 Village Center Cir #250
Las Vegas,  NV  89134
United States
Telephone: (702) 839-7200
URL: http://www.cvbt.com
Email: info@cvbt.com

CardioVascular BioTherapeutics Incorporated, based in Las Vegas, Nevada, is a biopharmaceutical firm that develops injectable and topical formulations. The company's products are based on the Fibroblast Growth Factor 1 (FGF-1) lead compound. FGF-1 supports the growth of blood vessels in the heart, tissues, and organs that have been damaged by an impaired blood supply. It is designed for patients with heart disease, peripheral artery disease, or diabetic wounds. It also can be used by people who have suffered a stroke. The firm employs proprietary technology in manufacturing its biopharmaceutical products. CardioVascular BioTherapeutics also is developing a protein-based drug treatment for osteoporosis. The firm's drug candidates are in clinical trials. The company is focusing on obtaining U.S. FDA approval for its FGF-1 treatments and delivery systems; establishing commercial manufacturing capacity; and marketing its biopharmaceuticals to patients, health care professionals, and third-party payers. CardioVascular BioTherapeutics is listed on the OTC:BB exchange under the CVBT symbol. The company was founded by Dr. Thomas J. Stegmann.

Org. Type: Corporation Equity Type: Public
Company Status: Active
Symbol: OTC/BB:CVBT

Products:
CardioVascular BioTherapeutics Inc--Company News

TecTerms:
 


Home About TecTrends About Us Contact Us Privacy Statement Terms and Conditions

TecTrends | P.O. Box 8120 | Berkeley CA 94707 | (510) 525-6220 | Email: tectrends@tectrends.com
© 2006 INFORMATION SOURCES INC | All rights reserved.